PATENT CLAIM ANALYSIS

Application Number: 16030659
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["514", "013800"]

Abstract:
The present invention relates to a method for treating gastrointestinal bleeding in a subject with severe von Willebrand Disease comprising administering to the subject at least one dose of recombinant von Willebrand Factor (rVWF) ranging from about 40 IU/kg to about 100 IU/kg, wherein the first dose further comprises recombinant Factor VIII (rFVIII).

Claim (Index 13):
The method of treatment of  claim 1 , wherein 40-60 IU/kg rVWF of said rVWF is administered every 8 to 12 hours for about 3 days to about 7 days, wherein said gastrointestinal bleeding is minor or moderate gastrointestinal bleeding.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 95.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13493926', '11317582', '14549404', '12630509', '13305334']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.783114556921358
- 35 USC 102 Novelty (BERT): 0.5568921671150036
- Combined Prediction Score: 0.7604923179407226
- Mean Citation Score: 358.204154
- Max Citation Score: 492.98743
- Similarity Product: 248.1463784708339

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test